Evidence map›Paper›PMID 41436188›Full record

ArticleBMJ global health2025

Global, regional and national estimates of obstetric fistula prevalence.

Saifuddin Ahmed, Rene Genadry, Bridget Asiamah, Mengjia Liang, Vandana Tripathi, Erin Anastasi

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Surgical interventions for treating vesicovaginal fistula in women.The Cochrane database of systematic reviews · 2026
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saifuddin AhmedPopulation, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA sahmed3@jhu.edu.ORCID 0000-0002-9884-4580
Rene GenadryDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0002-2050-1879
Bridget AsiamahUnited Nations Population Fund, New York, New York, USA.ORCID 0009-0007-2488-3142
Mengjia LiangUnited Nations Population Fund, New York, New York, USA.ORCID 0000-0002-2885-1697
Vandana TripathiFistula Care Plus Project, EngenderHealth, Washington, District of Columbia, USA.ORCID 0000-0002-8237-342X
Erin AnastasiUnited Nations Population Fund, New York, New York, USA.ORCID 0000-0002-2441-4916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe UN General Assembly in 2018 passed a resolution to eliminate obstetric fistula within a decade. Because the prevalence of obstetric fistula is not known, it is difficult to develop appropriate national and global health strategies to prevent, treat and eliminate the condition. We estimate the prevalence of obstetric fistula in 55 countries targeted by the UNFPA-led global Campaign to End Fistula Programme.

methodsWe used data on reported symptoms of obstetric fistula from 31 Demographic and Health Surveys conducted in 22 countries and applied a predictive model to estimate the global, regional and country-level prevalences of current obstetric fistula cases in target countries. Self-reported fistula symptoms are subject to over-reporting and misclassification biases. Using known estimates of clinically diagnostic validation from large population studies, we additionally corrected self-reported obstetric fistula estimates for misclassification errors.

resultsWe estimate the global fistula prevalence of about 457 000 (95% CI 303 000 to 709 000) among women aged 15-64 and about 386 000 (95% CI 256 000 to 599 000) among women of reproductive age (15-49). The obstetric fistula prevalence rate was almost two times higher in the sub-Saharan region (71 per 100 000 women) compared with Asia (36 per 100 000 women).

conclusionThe estimated prevalence of obstetric fistula is substantially lower than the previously cited numbers of 2 million women. The prevalence and incidence rates of obstetric fistula have likely declined over time due to a number of factors. Skilled birth attendance, access to emergency obstetric care and caesarean section deliveries have substantially increased in low- and middle-income countries with a concurrent decline in maternal mortality during the last two decades. The global Campaign to End Fistula, launched in 2003, together with other international efforts, has also targeted improving prevention and treatment of obstetric fistula during this period. This is a preventable and treatable condition, and the global community must mobilise to eliminate this devastating and tragic condition by ensuring that women have access to timely and quality emergency obstetric care, including safe surgical care for caesarean section.

Indexed as

Global HealthObstetric Labor ComplicationsAdolescentAdultFemaleHealth SurveysHumansMiddle AgedPregnancyPrevalenceYoung AdultMaternal health

Identifiers

PMID41436188
PMCPMC12730805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.